Mail Online
27 NOV 2017
Read article
Keeping Stock
20 NOV, 2017
TOP 10 BIOTECH COMPANIES THAT ARE PUSHING THE ENVELOPE IN THE MEDICAL FIELD
Born2Invest
20 NOV, 2017
A GLIMPSE AT THE GLOBAL BLOOD DISEASE MARKET
Technology.org
09 NOV, 2017
3 BREAKTHROUGH CANCER TREATMENTS YOU MAY NOT KNOW ABOUT, BUT SHOULD
Follow us on social media to get the latest news.
Alliance News
30 OCT, 2017
HEMOGENYX CHOOSES LAKEPHARMA TO DEVELOP CDX ANTIBODY TREATMENT
Proactive Investors
12 OCT, 2017
HEMOGENYX AIMS FOR REVOLUTION IN BLOOD CANCER TREATMENT
IB Times
09 OCT, 2017
HEMOGENYX LAUNCHING PRODUCTS THAT COULD TREAT BONE MARROW TRANSPLANTS WITHOUT CHEMOTHERAPY
Born2Invest
08 OCT, 2017
BIOMEDICAL STOCK TO WATCH OUT FOR
Digital Look
05 OCT, 2017
HEMOGENYX REVERSES INTO SILVER FALCON, ISSUES SHARES TO CORNELL UNI
A new era for the treatment of blood diseases
Our aim is to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy.